Literature DB >> 23497199

Targeting apoptosis by the remodelling of calcium-transporting proteins in cancerogenesis.

Charlotte Dubois1, Fabien Vanden Abeele, Natacha Prevarskaya.   

Abstract

Calcium is a universal messenger regulating many physiological functions, including the ability of the cell to undergo orderly self-destruction upon completion of its function, called apoptosis. In physiopathological conditions such as cancer, apoptotic processes become deregulated, leading to apoptosis-resistant phenotypes. Recently, perturbations of cellular calcium homeostasis have been described in apoptosis-resistant cell phenotypes. Thereby, new molecular actors have been identified, offering more accurate research possibilities in the field of apoptosis resistance and providing the bases for more rational approaches to cancer treatments. In this review, we focus on the calcium-transporting protein-dependent pathways involved in apoptosis, which are deregulated by cancer. We present the calcium-transporting proteins involved in the deregulation of apoptosis, and those chemotherapies that target actors in calcium-induced apoptosis.
© 2013 The Authors Journal compilation © 2013 FEBS.

Entities:  

Keywords:  apoptosis; calcium; cancer; chemotherapy; resistance

Mesh:

Substances:

Year:  2013        PMID: 23497199     DOI: 10.1111/febs.12246

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  13 in total

Review 1.  The Calcium-Signaling Toolkit in Cancer: Remodeling and Targeting.

Authors:  Sarah J Roberts-Thomson; Silke B Chalmers; Gregory R Monteith
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-08-01       Impact factor: 10.005

Review 2.  Ion channels in regulated cell death.

Authors:  Karl Kunzelmann
Journal:  Cell Mol Life Sci       Date:  2016-04-18       Impact factor: 9.261

Review 3.  Cell volume regulation in epithelial physiology and cancer.

Authors:  Stine F Pedersen; Else K Hoffmann; Ivana Novak
Journal:  Front Physiol       Date:  2013-08-30       Impact factor: 4.566

Review 4.  Endothelial Ca2+ Signaling and the Resistance to Anticancer Treatments: Partners in Crime.

Authors:  Francesco Moccia
Journal:  Int J Mol Sci       Date:  2018-01-11       Impact factor: 5.923

5.  Activation of TRPM7 by naltriben enhances migration and invasion of glioblastoma cells.

Authors:  Raymond Wong; Ekaterina Turlova; Zhong-Ping Feng; James T Rutka; Hong-Shuo Sun
Journal:  Oncotarget       Date:  2017-02-14

Review 6.  Ionophores: Potential Use as Anticancer Drugs and Chemosensitizers.

Authors:  Vivek Kaushik; Juan Sebastian Yakisich; Anil Kumar; Neelam Azad; Anand K V Iyer
Journal:  Cancers (Basel)       Date:  2018-09-27       Impact factor: 6.639

7.  Calcium-permeable ion channels in control of autophagy and cancer.

Authors:  Artem Kondratskyi; Maya Yassine; Kateryna Kondratska; Roman Skryma; Christian Slomianny; Natalia Prevarskaya
Journal:  Front Physiol       Date:  2013-10-02       Impact factor: 4.566

Review 8.  Ion channels and transporters in the development of drug resistance in cancer cells.

Authors:  Else K Hoffmann; Ian H Lambert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

9.  Targeting of short TRPM8 isoforms induces 4TM-TRPM8-dependent apoptosis in prostate cancer cells.

Authors:  Gabriel Bidaux; Anne-Sophie Borowiec; Charlotte Dubois; Philippe Delcourt; Céline Schulz; Fabien Vanden Abeele; Gilbert Lepage; Emilie Desruelles; Alexandre Bokhobza; Etienne Dewailly; Christian Slomianny; Morad Roudbaraki; Laurent Héliot; Jean-Louis Bonnal; Brigitte Mauroy; Pascal Mariot; Loïc Lemonnier; Natalia Prevarskaya
Journal:  Oncotarget       Date:  2016-05-17

10.  The Role of the Anti-Aging Protein Klotho in IGF-1 Signaling and Reticular Calcium Leak: Impact on the Chemosensitivity of Dedifferentiated Liposarcomas.

Authors:  Vanessa Delcroix; Olivier Mauduit; Nolwenn Tessier; Anaïs Montillaud; Tom Lesluyes; Thomas Ducret; Frédéric Chibon; Fabien Van Coppenolle; Sylvie Ducreux; Pierre Vacher
Journal:  Cancers (Basel)       Date:  2018-11-14       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.